Shanghai Pulmonary Hospital, Shanghai, China

This study is testing whether a combination of two immunotherapy drugs plus chemotherapy given before surgery can help shrink tumors in patients with stage II-III non-small cell lung cancer. The treatment is given to 54 patients who are scheduled for surgery, with the goal of red…

This study is testing whether the drug teniposide can help control advanced small cell lung cancer that has worsened despite standard chemotherapy. It is for patients whose cancer has a specific genetic feature called 'c-Myc-driven.' The main goal is to see if the drug shrinks tu…

This study is testing whether a combination of two targeted drugs can shrink tumors enough to allow surgery in patients with a specific type of advanced lung cancer (EGFR-mutant). The goal is to see if giving these drugs first can make previously inoperable tumors removable. Rese…

This study is testing whether a new drug called IBI363, combined with standard chemotherapy, can shrink stage 3 non-small cell lung cancer that is currently too advanced or complex to remove with surgery. The goal is to shrink the tumors enough so that surgery becomes a safe and …

This study is testing whether artificial intelligence can create PET scan images from regular CT scans to improve lung cancer diagnosis. Researchers will enroll 10,000 lung cancer patients to see if these AI-generated images match real PET scans in accuracy. The goal is to provid…

This study compares two drugs given at the end of lung surgery to help patients wake up with better breathing function. Researchers want to see if a newer drug called sugammadex helps patients recover their lung strength faster than the standard drug, neostigmine. The trial will …

This study is testing whether a new, long-acting numbing medicine provides better pain relief after lung surgery than the standard version. Researchers will compare pain levels and opioid use in 210 patients who receive either the new extended-release medicine, the standard medic…

This study aims to see if growing a patient's own lung cancer cells in a lab dish can help doctors choose the most effective treatment for them. Researchers will test drugs on these lab-grown cell clusters and see if the results match how well the patient responds to the same dru…

This study aims to better understand the different patterns of bronchiectasis, a chronic lung disease, in Chinese adults. Researchers will collect detailed health information and samples from 1500 patients to identify distinct patient groups. The goal is to use this knowledge to …